no statement of use filed
on 29 Jun 2020
Last Applicant/ Owned by
509 Madison Avenue, Suite 306
New York
NY
10022
Serial Number
86400401 filed on 19th Sep 2014
Registration Number
N/A
Correspondent Address
FRANCIS J. DUFFIN
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"PHARMACEUTICALS"
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment andRead More
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders
No 86400401
No Service/Collective Mark
No 204058/US002
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
29th Jun 2020 | ABANDONMENT - NO USE STATEMENT FILED |
29th Jun 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
01st Nov 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
31st Oct 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
31st Oct 2019 | EXTENSION 5 GRANTED |
30th Oct 2019 | EXTENSION 5 FILED |
30th Oct 2019 | TEAS EXTENSION RECEIVED |
18th May 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
16th May 2019 | EXTENSION 4 GRANTED |
16th May 2019 | EXTENSION 4 FILED |